Clinical Trial Update: A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A two-part Phase 1 trial evaluating the safety of NN9925 in healthy male subjects has completed, sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NN9925

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED